Clincosm LogoSign in Get a demo

Advanced Hepatocellular Carcinoma

Showing 1 - 25 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial (CD-801)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Oct 13, 2023

Advanced Hepatocellular Carcinoma Trial in Beijing (Neoantigen vaccine, I.M injection)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Neoantigen vaccine, I.M injection
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jul 31, 2023

Advanced Hepatocellular Carcinoma Trial in China (Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Penpulimab injection
  • +2 more
  • Wuwei, Gansu, China
  • +7 more
Jul 27, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (adebrelimab, camrelizumab plus apatinib)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • adebrelimab, camrelizumab plus apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Jun 21, 2023

Advanced Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
  • +46 more
May 22, 2023

Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • SZ003 CAR-NK
  • (no location specified)
Apr 25, 2023

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • EU307 CAR-T Cell
  • (no location specified)
Mar 13, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab+regorafenib)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib combined with TACE and Camrelizumab
  • Chengdu, Sichuan, China
    HuaXi hospital
Feb 12, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Advanced Hepatocellular Carcinoma Trial in Hangzhou (CT0180 Cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • CT0180 Cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Jan 27, 2023

Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • GDKM-100 injection
  • Zhuhai, Guangdong, China
    Zhuhai People'S Hospital
Jan 16, 2023

Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • GPC3 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Bifidobacterium Bifidum Oral Product
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022

Advanced Hepatocellular Carcinoma Trial in Shanghai (Tislelizumab, lenvatinib, US/CT-guided Percutaneous Cryoablation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Atezolizumab Plus Bevacizumab in Advanced HCC

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Atezolizumab plus bevacizumab
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Cha Medical Center
Oct 30, 2022

Advanced Hepatocellular Carcinoma Trial (Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    National Cancer Center, Korea
Oct 19, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)

Recruiting
  • Hepatocellular Carcinoma
  • Advanced Hepatocellular Carcinoma
  • Changhua, Taiwan
  • +8 more
Oct 19, 2022

Advanced Hepatocellular Carcinoma Trial in Shanghai (Biological/Vaccine: Low-dose group, Biological/Vaccine: Mid-dose group,

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Biological/Vaccine: Low-dose group
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Jul 27, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Advanced Hepatocellular Carcinoma Trial in London (Itacitinib (INCB039110))

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Itacitinib (INCB039110)
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Jul 14, 2022